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Chronic fatigue syndrome (CFS) is a disabling disorder, characterized by persistent or relapsing fatigue. Recent
studies have detected a decrease in cortical grey matter volume in patients with CFS, but it is unclear whether
this cerebral atrophy constitutes a cause or a consequence of the disease. Cognitive behavioural therapy (CBT)
is an effective behavioural intervention for CFS, which combines a rehabilitative approach of a graded increase
in physical activity with a psychological approach that addresses thoughts and beliefs about CFS which may
impair recovery.Here, we test the hypothesis that cerebral atrophy may be a reversible state that can amelio-
rate with successful CBT.We have quantified cerebral structural changes in 22 CFS patients that underwent CBT
and 22 healthy control participants. At baseline, CFS patients had significantly lower grey matter volume than
healthy control participants.CBT intervention led to a significant improvement in health status, physical activity
and cognitive performance. Crucially, CFS patients showed a significant increase in grey matter volume, loca-
lized in the lateral prefrontal cortex.This change in cerebral volume was related to improvements in cognitive
speed in the CFS patients. Our findings indicate that the cerebral atrophy associated with CFS is partially
reversed after effective CBT. This result provides an example of macroscopic cortical plasticity in the adult
human brain, demonstrating a surprisingly dynamic relation between behavioural state and cerebral anatomy.
Furthermore, our results reveal a possible neurobiological substrate of psychotherapeutic treatment.
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Introduction
The chronic fatigue syndrome (CFS) is an illness characterized
by profound disabling fatigue, of new or definite onset and
lasting at least 6 months. CFS substantially limits occupa-
tional, educational, social and personal activities (Fukuda
et al., 1994). Infectious, immunological, neuroendocrine,
sleep and psychological mechanisms have been proposed to
play a role, but the exact pathogenesis has still to be elucidated
(Prins et al., 2006). Several symptoms reported by CFS
patients—including fatigue; impaired concentration, atten-
tion and memory; and headache—suggest that the central
nervous system may be involved in the pathophysiology of the
syndrome. Several studies have reported structural abnor-
malities in the central nervous system of CFS patients, such
as focal white matter hyperintensities (Buchwald et al., 1992;
Natelson et al., 1993; Schwartz et al., 1994; Lange et al., 1999),
although other groups failed to replicate this finding
(Cope et al., 1995; Cope and David, 1996). In two recent
studies, we and others, using an automated procedure for
assessing cerebral abnormalities, observed marked reductions
in grey matter volume (de Lange et al., 2005), localized to the
lateral prefrontal cortex (Okada et al., 2004). Since grey matter
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volume reduction and white matter hyperintensities appear to
be tightly linked manifestations of the same pathophys-
iological process (Wen et al., 2006), together these results
provide converging evidence that CFS is associated with brain
atrophy. However, it remains unclear whether these altera-
tions are aetiological factors or a consequence of the disease.
One way to address this issue is to examine whether these
cerebral structural alterations change over the course of
the disease.
Structural neuroplasticity—the brain’s ability to undergo
structural alterations following environmental changes—has
become an accepted biological phenomenon, even in the
brain of adult primates (Kozorovitskiy et al., 2005). These
structural alterations range from biochemical parameters to
dendritic arborization, gliogenesis and perhaps even neuro-
genesis (Buonomano and Merzenich, 1998; Gross, 2000;
van Praag et al., 2000). Environmental impoverishment
evokes a down-regulation of cerebral structure, whereas
environmental enrichment can generate an up-regulation of
neuroplasticity (Rosenzweig and Bennett, 1996).
In this perspective, it is possible that the reduced grey
matter volume observed in CFS is an expression of
neuronal down-regulation caused by the environmental
impoverishment associated with CFS. Therefore, it is also
conceivable that improvements in health status of CFS
patients could lead to an up-regulation of this process. We
test these hypotheses by quantifying behavioural parameters
and cerebral structure in a sample of CFS patients both
before and after a well-known behavioural therapeutic
intervention: cognitive behavioural therapy.
Cognitive behavioural therapy (CBT) and graded exercise
programs have been shown to improve the health status of
CFS patients (Prins et al., 2001; Whiting et al., 2001;
Edmonds et al., 2004; Stulemeijer et al., 2005). CBT
combines a rehabilitative approach of a graded increase in
activity with a psychological approach which addresses
thoughts and beliefs about CFS which may impair recovery.
It is aimed at reducing perpetuating factors of CFS, like low
physical activity and a low sense of control over the
symptoms (Bleijenberg et al., 2003b). Central CBT compo-
nents for CFS include explanation of the aetiological model,
motivation for CBT, challenging and changing of fatigue-
related cognitions, achievement and maintenance of a basic
amount of physical activity, gradual increase in physical
activity, and planning work rehabilitation or rehabilitation
in other personal activities (Prins et al., 2006).
In this study we quantified cerebral structure and
behavioural parameters (physical activity, cognitive perfor-
mance and experienced fatigue) in a sample of CFS patients
both before and after CBT. We hypothesized that CFS
patients would show a reduction in grey matter volume
compared to healthy controls before CBT, and an improve-
ment in grey matter volume following CBT. Moreover, we




We restricted our investigation to female participants, since CFS
predominantly affects women, and in view of the differences in
brain morphology and size between men and women (Gur et al.,
1991). Twenty-nine female patients who were diagnosed with CFS
were willing to take part in the study. Of these, four patients
withdrew from CBT, one patient was not willing to participate in
the follow-up scan, one patient had to be excluded due to poor
quality of the MR image, and one patient manifested somatic
comorbidity during treatment. The remaining 22 patients con-
formed to the US Centers for Disease Control and Prevention
(CDC) criteria for CFS (Fukuda et al., 1994). We included 22
healthy control subjects that were matched on sex, age and
education. None of the participants took any drugs that acted on
the central nervous system. Demographic characteristics of the
final set of participants are listed in Table 1.
All participants took part in the study after giving written
informed consent according to institutional guidelines of the local
ethics committee and in accordance with the Helsinki Declaration
of 1975, as revised in 1983.
Multidimensional assessments and structural brain images were
made at baseline (i.e. before CBT) and at follow-up (i.e. after
CBT) in all CFS patients. Healthy control participants were
assessed at a comparable time interval.
Cognitive behavioural therapy
Participants engaged in cognitive behavioural therapy for on
average 16 sessions of 1 h over a period of 6–9 months. During
CBT, fatigue-related cognitions were challenged to diminish
somatic attributions, to improve sense of control over symptoms
and to facilitate behavioural changes. In parallel, a structured
physical activity program was implemented. Furthermore, a work
rehabilitation schedule was drawn up in order to realize a gradual
work reentry. Final sessions of CBT dealt with relapse prevention
and further improvement of self-control. This procedure is
described in detail elsewhere (Bleijenberg et al., 2003a).
Behavioural and psychological assessment
We collected several behavioural and psychological measures before
and after CBT in all CFS patients to quantify both objective and
subjective markers of fatigue and physical and mental inability.
The physical activity level of the CFS patients was assessed by
actometer measurements for a period of 2 weeks preceding the
baseline scan, and for a period of 2 weeks preceding the follow-up
scan. The actometer (Actilog V3.0) is a motion sensing device, worn
Table 1 Demographic characteristics of participants
CFS HC P
Male/Female participants 0/22 0/22
Age in years 36.6 (2.5) 37.1 (2.2) 0.88
Educational attainment
(1=low to 7=high)
4.7 (0.30) 4.6 (0.49) 0.92
Time between baseline and
follow-up in days
312 (17) 296 (20) 0.56
CFS duration in years 5.8 (0.79) 0 (0) 50.001
Values are given as means (SE).
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at the ankle, which can register and quantify human physical activity.
The average physical activity score reflects the average physical
activity level over a total 12-day period (the first and last day of
registration were omitted to obtain 12 complete registration days)
and it is expressed as the mean number of accelerations per 5-min
period (Vercoulen et al., 1997). On the basis of the average physical
activity score, we distinguished between pervasively passive and
relatively active CFS patients (van der Werf et al., 2000).
To assess cognitive speed, we used two speeded reaction time
tasks: the digit symbol substitution test of the Wechsler Adult
Intelligence Scale (WAIS-dst) (Wechsler, 1981) and the choice
reaction time task (CRT) (Vercoulen et al., 1998). We also used the
simple reaction time task (SRT) to control for sensorimotor speed.
In the WAIS-dst, a series of symbols is presented that has to be
decoded as fast as possible within a preset 90 s limit based on a key
translating the nine different symbols into the digits 1–9. In both the
CRT and SRT tasks, subjects have to move as quickly as possible to a
target light when it is flashed. In the SRT, only one target was used,
whereas in the CRT three different targets were used. Therefore,
although both tasks challenge subjects’ speed of sensorimotor
processing, CRT places additional demands on response selection.
Each patient engaged in 30 trials of SRT and CRT.
Perceived fatigue severity was assessed by a subscale of the
checklist individual strength (Vercoulen et al., 1994; Dittner et al.,
2004). In this questionnaire, the patient is asked about fatigue in
the 2 weeks preceding the assessment. The subscale consists of
eight items, each scored on a 7-point Likert scale (range 8–56).
The questionnaire has good reliability (Cronbach’s  varying from
0.83 to 0.92) and discriminative validity (Vercoulen et al., 1994).
Finally, perceived disability was measured by the sickness impact
profile (Bergner et al., 1981). This widely used measure has good
reliability and content validity (de Bruin et al., 1992).
Imaging protocol
High-resolution anatomical images of the whole brain were acquired
on a 1.5 T Siemens Sonata whole-body scanner (Erlangen, Germany)
using a magnetization prepared rapid acquisition gradient echo
sequence, acquiring 176 sagittal slices with a echo time (TE) of
3.93 ms, a repetition time (TR) of 2250 ms, voxel size of 1 mm3, flip
angle (FA) of 15 and a field-of-view (FOV) of 256 mm. This
sequence gives excellent grey/white matter segmentation, and high
contrast-to-noise images of the entire brain at isotropic 1 mm
resolution (Brant-Zawadzki et al., 1992; Deichmann et al., 2000).
Images were analysed using VBM (Ashburner and Friston, 2000),
a fully automated technique for computational analysis of differ-
ences in global and local grey and/or white matter volume. VBM is
a set of procedures within the framework of SPM (www.fil.ion.
ucl.ac.uk/spm). The reliability of VBM for quantifying brain tissue
volume has been extensively validated (Good et al., 2001; Chard
et al., 2002). We first created a custom template and priors with
reduced population bias, on the basis of both baseline and follow-up
MR scans. This procedure entailed affine spatial normalization of
all scans to the International Consortium for Brain Mapping
template (Montreal Neurological Institute, Montreal, Canada),
which approximates Talairach and Tournoux space (Talairach and
Tournoux, 1988). The normalized images of all participants (both
CFS patients and HC) were averaged and smoothed with a Gaussian
kernel of 8 mm full-width at half-maximum. This procedure is
described in detail by (Good et al., 2001). Global (differences) in
grey matter volume and white matter volume were quantified
by integrating the tissue probabilities over all voxels. In order
to avoid possible edge effects around the border between grey
and white matter, we used an absolute grey and white matter
threshold of P50.15.
Assessment of both regional and global differences in grey
matter volume (GMV) between groups was preceded by the
following pre-processing steps: (i) spatial normalization of all
images to a standardized anatomical space by removing differences
in overall size, position and global shape; (ii) extraction of grey
and white matter from the normalized images; (iii) correction
for volume changes induced by normalization (i.e. modulation)
and (iv) smoothing with a Gaussian kernel of 12 mm full-width
at half-maximum. Assessment of longitudinal changes in regional
GM involved the following steps: (i) coregistration of baseline and
follow-up images for each participant; (ii) spatial normalization
of baseline and follow-up image to a standardized anatomical
space, on the basis of the estimated normalization parameters for
the baseline image; (iii) extraction of grey and white matter from
the normalized images; (iv) calculation of the difference images
by subtracting the baseline GMV image from the follow-up GMV
image and (v) spatially smoothing the difference images with a
Gaussian kernel of 12 mm full-width at half-maximum. This
protocol has been successfully applied in a previous longitudinal
study (Draganski et al., 2004).
Statistical analysis
Global differences in grey and white matter volume between
groups were assessed using a two-tailed multivariate linear
regression analysis that considered age as a covariate.
Regional (i.e. voxel-by-voxel) differences in grey matter volume
between groups were assessed with t-tests using the general linear
model, considering age and total grey matter volume as
confounding covariates, and correcting the results for search
volume by using family-wise error (FWE) correction. We used
small volume correction for investigation of regional effects in
prefrontal cortex, on the basis of a previous study showing
reduced GM in CFS in bilateral prefrontal cortex (Okada et al.,
2004). We defined regions of interest (ROIs) with a radius equal
to the smoothing kernel of our images around the peak
coordinates of that study. All reported regional effects survived
correction for search volume using both FWE (Worsley et al.,
1996) and FDR (Genovese et al., 2002) correction for multiple
comparisons. To investigate whether CBT led to a differential
increase in global grey matter between groups, we used a one-
tailed multivariate linear regression analysis that considered age as
a covariate. Relations between (changes in) CFS-related features
and (changes in) GMV were assessed by means of one-tailed
Spearman’s correlation analyses. Significance level was set at
P50.05 in all analyses. We screened for potential outliers and
their influence on the correlation analyses. In order to identify
univariate outliers, we Z-transformed our dependent variable of
interest and employed an absolute Z-score of |Z|42.5 as an outlier
criterion. We also checked for multivariate outliers using
Mahalanobis D2 distance measure, considering an observation an
outlier if the probability associated with its D2 is 0.001 or less.
Results
We measured global and local GMV in CFS patients and
matched healthy control subjects at two time-points: baseline
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(preceding cognitive behavioural therapy) and follow-up
(after the CFS patients had undergone CBT treatment).
Baseline
CFS patients had significantly lower GMV than controls at
baseline [t(2,41) = 2.55; P= 0.015], showing an average reduc-
tion of 5.5% in GMV compared to controls (Fig. 1A). There
were no significant differences between groups in global white
matter [t(2,41) = 1.32; P= 0.194]. GMV decreased with age in
both groups [t(2,41) = –4.27; P50.001], at an average rate
of 3.1 ml/year (Fig. 1B). An analysis of regional volume
differences between groups did not show any significant
differences in local grey matter between groups that survived
correction for multiple comparisons over the whole brain.
We collected several behavioural and psychological
measures before and after CBT in all CFS patients to quantify
both objective and subjective markers of fatigue and physical
and mental inability. We measured cognitive speed with
two speeded tasks: the digit symbol subtest of the WAIS
(Wechsler, 1981) and the CRT (Vercoulen et al., 1998).
As illustrated in Fig. 4A and B, both measures of
cognitive speed bore relation to baseline GMV in the CFS
patients. CFS patients who could complete fewer items on
the WAIS-dst exhibited lower GMV (r= 0.64, P= 0.001;
Fig. 4A). Similarly, CFS patients who were slower at the
CRT exhibited lower GMV (r= –0.40, P= 0.033; Fig. 4C).
Importantly, behavioural performance on the SRT, which
measures sensorimotor rather than cognitive speed, showed
no significant correlation with GMV (r= –0.15, P= 0.26).
The physical activity level of the CFS patients was assessed
by actometer measurements for a period of 2 weeks preceding
the baseline scan, and for a period of 2 weeks preceding the
follow-up scan. The activity scores and patterns of the CFS
patients are listed in Table 1. Although there was no
significant linear relationship between the mean physical
activity scores and GMV (r= 0.23; P= 0.15), the overall
physical activity pattern predicted GMV within the CFS
patient group: passive CFS patients had lower GMV than
active CFS patients [t(20) = –2.17; P= 0.042]. Note that passive
and active CFS patients did not significantly differ from each
other in terms of age, degree of functional impairments or
perceived fatigue.
We also collected subjective reports on perceived fatigue
and disability. CFS patients reported more functional
impairments and more fatigue than healthy controls
(Table 2), but there were no significant correlations between
GMV and these subjective reports (all P40.10).
Follow-up
Within the healthy group, GMV did not change signifi-
cantly between the first and second measurement [differ-
ence: –0.21 1.7 ml, mean SE; t(21) = –0.13; P= 0.45;
Fig. 2A]. Conversely, there was an increase in GMV in
the CFS group [difference: 4.7 2.3 ml, mean SE;
t(21) = 2.08; P= 0.025; Fig. 2A], such that the initial
between-group difference in GMV decreased by 12%
following CBT. This between-groups difference in GMV
change resulted in a significant Group X Time interaction
[t(2,41) = 1.82; P= 0.038]. Patient’s age also influenced the
increase in GMV: the potential for an increase in GMV
linearly decreased with age (r= –0.45; P= 0.018; Fig. 2B). In
spite of the increase in GMV in the CFS patients after CBT,
GMV was still lower in the CFS group than in the HC
group [t(2,41) = 2.21; P= 0.033]. Overall, the test–retest
reliability of the GMV measurements was high, both in the
healthy control group (r= 0.991; P50.001) and the CFS
patients (r= 0.990; P50.001).
Fig. 1 Grey matter volume at baseline measurement. (A) Healthy controls (HC, in grey) have significantly larger grey matter volume
(GMV) than CFS patients (CFS, in black). (B) Both groups show a similar decline in GMV as a function of ageing.
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Within-group analysis of regional changes in grey matter
volume between the pre- and post-CBT scans revealed
significant regional increases bilaterally in the inferior
frontal gyrus [left IFG: (–36, 39, 17), t(21) = 5.49,
PFWE = 0.010, PFDR = 0.025; right IFG: (39, 35, 23),
t(21) = 5.49, PFWE = 0.005, PFDR = 0.011] for the CFS group
(Fig. 3), but no changes for the healthy controls. Both these
clusters were located at the most dorsal portion of the
inferior frontal gyrus and in the depth of the middle frontal
sulcus, within the borders of cyto-architectonically
defined Brodmann area 46/9 (Rajkowska and Goldman-
Rakic, 1995).
In terms of cognitive speed, CFS patients became faster
on the CRT (t21 = 2.30, P= 0.032), while they did not show





CIS fatigue (8^56)a 48.4(1.3) 29.3 (2.9) 19.0 (2.9)
SIP total (0^9937)a 1334 (124) 550 (115) 784 (128)
Physical activity
Mean actometer score 63.5 (4.6) 73.2 (3.5) +9.7 (4.8)
Pervasively passive (%) 32 9 23
Relatively active (%) 68 91 +23
Cognitive speed
WAIS-dst 60.2 (2.8) 62.5 (2.9) 2.3 (1.6)NS
CRT (ms) 348 (14.2) 329 (11.5) 19.4 (8.4)
SRT (ms) 307 (11.6) 297 (12.8) 10.3 (9.6)NS
Cerebral volume
Grey matter (ml) 669.4 (14.4) 674.1 (15.1) +4.7 (2.3)
White matter (ml) 406.1 (8.9) 404.7 (8.9) 1.4 (1.0)NS
Healthy controls
Functional status
CIS fatigue (8^56)a 21.2 (2.4) 18.7 (2.1) 2.5 (2.7)NS
SIP total (0^9937)a 131 (63) 169 (69) +38 (36)NS
Cerebral volume
Grey matter (ml) 708.2 (12.0) 708.0 (12.6) 0.2 (1.7)NS
White matter (ml) 423.2 (9.0) 421.4 (8.7) 1.8 (1.7)NS
Values are given as means (SE).
aRange of the scale.NS=Not significant. p50.1. p50.05.
p50.001.
Fig. 2 Effect of CBTon grey matter volume. (A) There is a significant increase in GMV between baseline and follow-up in CFS patients, but
not in healthy control subjects. (B) There is a negative correlation between the increase in GMV following CBTand the patient’s age.
Fig. 3 Anatomical localization of grey matter volume increase.
Results are superimposed on the average normalized brain of all
CFS patients. There is a significant increase in prefrontal grey
matter volume (BA 46/9) as a result of CBT in CFS patients.
(A) sagittal view. (B) Coronal view. (C) Axial view. Results are
displayed at P50.001 uncorrected, for display purposes.
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a significant improvement on the WAIS-dst (t21 = 1.40,
P= 0.18). Importantly, the change in cognitive speed was
correlated with the change in GMV (WAIS-dst: r= 0.41,
P= 0.028; CRT: r= 0.42, P= 0.027; Fig. 4C and D). Thus, a
larger behavioural improvement in cognitive speed was
related to a larger increase in GMV following CBT.
There were correlations between local grey matter increase
and CRT [left PFC: (–38, 39, 17), T= 2.15, r= 0.43, P= 0.022,
k= 113 voxels; right PFC: (22, 47, 36), T= 2.46, r= 0.48,
P= 0.011, k= 691 voxels], and between local grey matter
increase and WAIS-dst in the right PFC [(26,38,49), T= 3.45,
r= 0.61, P= 0.001, k= 1636]. These results were obtained by
focusing the search within the prefrontal cortex, and they
should therefore be considered as post hoc confirmatory
analyses.
Patients’ sensorimotor speed, as indexed by the SRT, did
not change (t21 = 1.08, P= 0.30), and there was no correlation
between SRT change and the GMV increase (r= 0.24,
P= 0.14).
There was a trend of CFS patients becoming more
physically active following CBT [t(21) = 2.02, P= 0.056].
This increase in physical activity level was marginally
correlated with the increase in GMV (r= 0.30; P= 0.086).
Following CBT, CFS patients reported less functional
impairments (SIP-total) and experienced less fatigue (CIS-
fatigue), while healthy control subjects did not report any
differences in fatigue on these measures. However, there
was no significant relation between the GMV changes and
changes in these subjective ratings.
Analysis of outliers did not detect any univariate or
multivariate outliers. When using a lenient criterion for
univariate outlier detection (|Z|42) there were two outliers
in our analysis of changes in GMV (Z= –2.18 and Z= 2.24),
corresponding to one patient showing a GM decrease of
18.5 ml and one patient showing a GM increase of
28.5 ml. When removing these outliers, the relationship
between the dynamics in CRT and GMV, as well as between
age and the increase in GMV were still significant or still
tended to significance, while the correlation between
changes in WAIS-dst and GMV was no longer significant.
The same was true when using a lenient criterion for
multivariate outlier detection [p(D2)50.05].
Fig. 4 Correlation between cognitive speed and GMV within the CFS patient group.There is a significant correlation between cognitive
speed and GMV at baseline: (A) WAIS-dst; and (B) CRT.There is also a significant correlation between the improvement in cognitive speed
and the increase in GMV: (C) WAIS-dst and (D) CRT.
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Discussion
In this study we assessed the cerebral plasticity of grey
matter atrophy previously observed in CFS patients. The
reduction in GMV observed in these patients was partially
reversed following the behavioural improvements associated
with CBT.
Baseline findings
Confirming previous observations (Okada et al., 2004; de
Lange et al., 2005) we found that CFS patients exhibited
reduced cerebral GMV compared to healthy control sub-
jects, amounting to a reduction of 5%. Within the CFS
patient group, differences in physical activity had a cerebral
counterpart: Physically passive CFS patients had lower
GMV than relatively active CFS patients, in line with an
earlier study (de Lange et al., 2005). This observation fits
with reports of a down-regulation of cell proliferation and
neurogenesis in sedentary rodents, as compared to rodents
who were in an environment that allowed them to exert
physical exercise (van Praag et al., 1999). Functional
neuroplasticity related to cardiovascular exercise has also
been found in humans (Colcombe et al., 2004).
However, the GMV changes were not exclusively driven by
reduction in physical activity. We found that CFS patients
with low speed of information processing showed lower
GMV. To our knowledge, a relation between information
processing speed and GMV has not been documented before.
It remains to be seen whether speed of information processing
could influence cerebral structure independently from the
level of physical activity, and whether a similar relationship
between cognitive performance and GMV can be found in
healthy controls.
Treatment effects
Following CBT, CFS patients showed significant improve-
ments in health status, physical activity and cognitive
performance. These behavioural and cognitive changes had
a cerebral counterpart: the CFS patient group revealed a
significant GMV increase. Furthermore, the increase in
GMV bore relation to the improvement in information
processing speed, i.e. bigger improvements in information
processing speed were related to larger increases in GMV.
The increase in GMV fits with numerous reports on
up-regulation of neuroplasticity in rodents and monkeys
following enrichment of the environment (Rosenzweig and
Bennett 1996; Gross, 2000; van Praag et al., 2000). The
macroscopic effects we report arise from a comparison of
the average magnetic properties of tens of thousands of
neurons and glial cells. Accordingly, these effects can be
the result of neuroplastic changes occurring at several levels,
including dendritic spine density, dendritic length and
branching complexity, expression of spine and synapse-
related proteins. Given that neurogenesis in adult mam-
malian neocortex appears negligible, if present at all
(Bhardwaj et al., 2006), it appears reasonable to interpret
our findings as an instance of dendritic growth and/or
synaptogenesis following environmental enrichment.
The increase in GMV was localized to the lateral prefrontal
cortex, within cyto-architectonically defined Brodmann Area
46/9 (Rajkowska and Goldman-Rakic, 1995). In primates,
neuroplasticity following environmental enrichment has been
observed in the prefrontal cortex (Kozorovitskiy et al., 2005),
as an up-regulation of the overall number of spines and
presynaptic protein levels, probably reflecting an overall
increase in the number of excitatory synapses. It appears
plausible that the effects we observe may be a macroscopic
manifestation of similar processes, induced by the increase in
environmental complexity evoked by CBT.
The lateral prefrontal cortex is an essential node of the
network subserving executive functions, as shown by experi-
mental work from neuropsychology, functional imaging in
humans, as well as lesion and single-cell recording studies in
the monkey (Miller and Cohen, 2001). Lesions in lateral
prefrontal cortex often lead to significant reductions in the
generation of appropriate goal-directed voluntary behaviour
(Jacobsen, 1935; Goldman-Rakic, 1987; Passingham et al.,
2005), which can clinically manifest itself as apathy (Levy and
Dubois, 2006). The aim of CBT for CFS patients is to establish
and maintain a basic amount of physical activity, to plan
work or other personal activities, and to gain control over
their symptoms (Prins et al., 2006). Given the overlap
between the symptoms associated with lateral prefrontal
cortical damage and the behaviour that CBT aims to reduce, it
appears hardly coincidental that the degree of success of CBT
outcome was related to the degree of recovery in grey matter
volume in the lateral prefrontal cortex.
Age effects
In line with previous studies (Pfefferbaum et al., 1994; Good
et al., 2001), we observed a decrease in GMV with age.
Interestingly, we also observed that the post-treatment
increase in GMV was dependent on the age of the patient:
older patients showed less improvement (or even a decrease)
in GMV. This finding suggests that the age-dependent
reduction in neuroplastic potential, already documented in
animal studies (Kuhn et al., 1996), is also present in humans.
Limitations
Although there was a significant increase in GMV in the
CFS patient group, this increase in GMV was a relatively
modest portion (12%) of the overall difference in GMV
between CFS patients and controls. This finding does not
necessarily imply that a substantial portion of the GMV
reduction observed in CFS patients is irreversible, even after
disease recovery. Namely, not all patients benefited from
CBT, and some patients were not yet fully recovered at the
time of scanning. Moreover, the GMV increase was
dependent on the age of the participant: older CFS patients
did not show any increase in GMV, thereby attenuating the
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GMV increase observed in the group. Finally, it is
conceivable that the cellular and neurophysiological changes
follow a slower dynamic than the behavioural improve-
ments. Future studies are needed that follow patients in
different age categories at multiple time points over several
years to quantify the reversibility of GMV changes following
disease recovery. Another limitation of this study is that we
did not compare CFS patients treated with CBT with CFS
patients that did not undergo CBT treatment. Therefore, we
cannot exclude that the cerebral alterations are due to non-
specific factors other than the CBT treatment. However, the
specific effectivity of CBT, compared to other treatments,
has been well-established earlier (Prins et al., 2001; Whiting
et al., 2001; Edmonds et al., 2004; Stulemeijer et al., 2005),
suggesting that the behavioural effects are likely to be the
result of CBT, rather than other unspecific factors.
It may seem somewhat surprising that although we found
global differences in GMV between CFS patients and
healthy controls, as well as a significant difference between
the groups in the increase in global GMV after treatment,
we did not find any significant between-groups differences
in regional GMV at baseline or follow-up. It is likely that
these differences in the results of global and local GMV
effects reflect the different statistical sensitivity of these
measures. First, global GMV provides a single data-point
per subject and therefore it does not require a correction
for multiple comparisons. In contrast, local GMV provides
a large number of data-points per subject. Statistical infer-
ences on this measure need to be corrected for multiple
comparisons, a conservative procedure (Worsley et al. 1996;
Genovese et al., 2002). Second, global GMV is the integral
of local GMV throughout the cortex, i.e. the combined
result of regional effects. Assuming a consistent direction of
change of the regional effects, global GMV is a more
sensitive index than local effects. Third, global GMV is not
influenced by the inter-subject variations in brain mor-
phology (that remain even after spatial normalization, see
(Ashburner and Friston, 1999, 2000). In contrast, local
GMV effects are influenced by the degree of spatial overlap
of a given effect across subjects. Taken together, these
considerations point to a different sensitivity of local versus
global GMV measures, and this is likely to account for the
fact that at baseline we could show lower global GMV in
the CFS patients, but no supra-threshold regional differ-
ences in GMV.
A final limitation of the current study may be that we did
not control the time of menstrual cycle in the acquisition of
anatomical measurements. This factor posits a small but
measurable contribution to MRI images. However, menstrual
cycle affects cerebro-spinal fluid volume (Grant et al., 1988;
Bydder and Hajnal, 1997), rather than GMV. Moreover, it
seems unlikely that there were any systematic differences in
menstrual cycle between the groups at baseline or follow-up.
Therefore, the lack of control of the menstrual cycle is
unlikely to have systematically biased our results.
Conclusions
Our findings indicate that the cerebral atrophy associated
with CFS is partially reversed after effective CBT. This
demonstrates the surprisingly dynamic relation between
behavioural state and cerebral atrophy and points to a
potential neurobiological mechanism of cognitive behav-
ioural treatment.
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